242 related articles for article (PubMed ID: 31841757)
1. Inhibition of microRNA-92a ameliorates lipopolysaccharide-induced endothelial barrier dysfunction by targeting ITGA5 through the PI3K/Akt signaling pathway in human pulmonary microvascular endothelial cells.
Xu F; Zhou F
Int Immunopharmacol; 2020 Jan; 78():106060. PubMed ID: 31841757
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-92a serves as a risk factor in sepsis-induced ARDS and regulates apoptosis and cell migration in lipopolysaccharide-induced HPMEC and A549 cell injury.
Xu F; Yuan J; Tian S; Chen Y; Zhou F
Life Sci; 2020 Sep; 256():117957. PubMed ID: 32534035
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-92a antagonism attenuates lipopolysaccharide (LPS)-induced pulmonary inflammation and injury in mice through suppressing the PTEN/AKT/NF-κB signaling pathway.
Fu L; Zhu P; Qi S; Li C; Zhao K
Biomed Pharmacother; 2018 Nov; 107():703-711. PubMed ID: 30138892
[TBL] [Abstract][Full Text] [Related]
4. Triptolide inhibits angiogenesis in microvascular endothelial cells through regulation of miR-92a.
Xu X; Tian L; Zhang Z
J Physiol Biochem; 2019 Nov; 75(4):573-583. PubMed ID: 31691162
[TBL] [Abstract][Full Text] [Related]
5. The regulatory effect of microRNA-21a-3p on the promotion of telocyte angiogenesis mediated by PI3K (p110α)/AKT/mTOR in LPS induced mice ARDS.
Zhou Y; Yang Y; Liang T; Hu Y; Tang H; Song D; Fang H
J Transl Med; 2019 Dec; 17(1):427. PubMed ID: 31878977
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-26a inhibits wound healing through decreased keratinocytes migration by regulating ITGA5 through PI3K/AKT signaling pathway.
Jiang Z; Wei J; Yang W; Li W; Liu F; Yan X; Yan X; Hu N; Li J
Biosci Rep; 2020 Sep; 40(9):. PubMed ID: 32955094
[TBL] [Abstract][Full Text] [Related]
7. Different concentrations of lipopolysaccharide regulate barrier function through the PI3K/Akt signalling pathway in human pulmonary microvascular endothelial cells.
Zheng X; Zhang W; Hu X
Sci Rep; 2018 Jul; 8(1):9963. PubMed ID: 29967433
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-92a promotes epithelial-mesenchymal transition through activation of PTEN/PI3K/AKT signaling pathway in non-small cell lung cancer metastasis.
Lu C; Shan Z; Hong J; Yang L
Int J Oncol; 2017 Jul; 51(1):235-244. PubMed ID: 28534966
[TBL] [Abstract][Full Text] [Related]
9. Ghrelin protects against lipopolysaccharide-induced acute respiratory distress syndrome through the PI3K/AKT pathway.
Zhang L; Ge S; He W; Chen Q; Xu C; Zeng M
J Biol Chem; 2021 Sep; 297(3):101111. PubMed ID: 34437900
[TBL] [Abstract][Full Text] [Related]
10. Anthrahydroquinone‑2,6‑disulfonate attenuates PQ‑induced acute lung injury through decreasing pulmonary microvascular permeability via inhibition of the PI3K/AKT/eNOS pathway.
Li N; Yi Y; Chen J; Huang Y; Peng J; Li Z; Wang Y; Zhang J; Xu C; Liu H; Li J; Liu X
Int J Mol Med; 2024 Jul; 54(1):. PubMed ID: 38874017
[TBL] [Abstract][Full Text] [Related]
11. Propofol promotes migration, alleviates inflammation, and apoptosis of lipopolysaccharide-induced human pulmonary microvascular endothelial cells by activating PI3K/AKT signaling pathway via upregulating APOM expression.
Wang L; Tang X; Li S
Drug Dev Res; 2022 Apr; 83(2):397-406. PubMed ID: 34418885
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-877-5p alleviates ARDS via enhancing PI3K/Akt path by targeting CDKN1B both in vivo and in vitro.
Li K; Huang Z; Tian S; Chen Y; Yuan Y; Yuan J; Zou X; Zhou F
Int Immunopharmacol; 2021 Jun; 95():107530. PubMed ID: 33735715
[TBL] [Abstract][Full Text] [Related]
13. PEAR1 suppresses the proliferation of pulmonary microvascular endothelial cells via PI3K/AKT pathway in ALI model.
Zhan Q; Ma X; He Z
Microvasc Res; 2020 Mar; 128():103941. PubMed ID: 31678362
[TBL] [Abstract][Full Text] [Related]
14. CircRSU1 alleviates LPS-induced human pulmonary microvascular endothelial cell injury by targeting miR-1224-5p/ITGA5 axis.
Cheng Y; Wang F; Guo C; Yuan S; Li J; Zhang Y
Gen Physiol Biophys; 2024 Jan; 43(1):1-11. PubMed ID: 38312030
[TBL] [Abstract][Full Text] [Related]
15. Vaspin protects against LPS‑induced ARDS by inhibiting inflammation, apoptosis and reactive oxygen species generation in pulmonary endothelial cells via the Akt/GSK‑3β pathway.
Qi D; Wang D; Zhang C; Tang X; He J; Zhao Y; Deng W; Deng X
Int J Mol Med; 2017 Dec; 40(6):1803-1817. PubMed ID: 29039444
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of microRNA-100-5p attenuates the endothelial cell dysfunction by targeting HIPK2 under hypoxia and reoxygenation treatment.
Zheng H; Sun Y; Shu X; Gao Q; Chen X
J Mol Histol; 2021 Oct; 52(5):1115-1125. PubMed ID: 34213736
[TBL] [Abstract][Full Text] [Related]
17. MiR-150 attenuates LPS-induced acute lung injury via targeting AKT3.
Li P; Yao Y; Ma Y; Chen Y
Int Immunopharmacol; 2019 Oct; 75():105794. PubMed ID: 31398659
[TBL] [Abstract][Full Text] [Related]
18. Unfractionated heparin ameliorates pulmonary microvascular endothelial barrier dysfunction via microtubule stabilization in acute lung injury.
Mu S; Liu Y; Jiang J; Ding R; Li X; Li X; Ma X
Respir Res; 2018 Nov; 19(1):220. PubMed ID: 30442128
[TBL] [Abstract][Full Text] [Related]
19. MiR-135a Protects Vascular Endothelial Cells Against Ventilator-Induced Lung Injury by Inhibiting PHLPP2 to Activate PI3K/Akt Pathway.
Yan X; Li W; Yang L; Dong W; Chen W; Mao Y; Xu P; Li D; Yuan H; Li YH
Cell Physiol Biochem; 2018; 48(3):1245-1258. PubMed ID: 30045018
[TBL] [Abstract][Full Text] [Related]
20. Regulation of miR-92a on vascular endothelial aging via mediating Nrf2-KEAP1-ARE signal pathway.
Liu H; Wu HY; Wang WY; Zhao ZL; Liu XY; Wang LY
Eur Rev Med Pharmacol Sci; 2017 Jun; 21(11):2734-2742. PubMed ID: 28678311
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
